The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: Effect of dose

27Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

High-risk strains of human papillomavirus, including HPV 16, cause human cervical carcinomas, due in part to the activity of their E6 oncogene. E6 interacts with a number of cellular proteins involved in host-initiated apoptotic responses. Paradoxically, literature reports show that E6 can both protect cells from and sensitize cells to tumor necrosis factor (TNF). To examine this apparent contradiction, E6 was transfected into U2OS cells and stable clones were treated with TNF. Intriguingly, clones with a high level of E6 expression displayed an increased sensitivity to TNF by undergoing apoptosis, while those with low expression were resistant. Furthermore, TNF treatment of cells in which the expression of E6 was regulated by the addition of doxycycline demonstrated clearly that while low levels of E6 protect cells from TNF, high levels sensitize cells. Together, these results demonstrate that virus -host interactions can be complex and that both quantitative and qualitative aspects are important in determining outcome. © 2005 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Filippova, M., Brown-Bryan, T. A., Casiano, C. A., & Duerksen-Hughes, P. J. (2005). The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: Effect of dose. Cell Death and Differentiation, 12(12), 1622–1635. https://doi.org/10.1038/sj.cdd.4401678

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free